Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Comprehensive Validation Study of Quality-of-Life Questionnaire Using Objective Clinical Measures: Breast Cancer Treatment Outcome Scale (BCTOS), Brazilian Portuguese Version

Full text
Author(s):
Brandini da Silva, Fabiola Cristina [1, 2] ; da Silva, Jonathas Jose [1, 2] ; Sarri, Almir Jose [1] ; Paiva, Carlos Eduardo [2, 3] ; da Costa Vieira, Rene Aloisio [2, 4]
Total Authors: 5
Affiliation:
[1] Barretos Canc Hosp, Dept Physiotherapy, Barretos - Brazil
[2] Barretos Canc Hosp, Postgrad Program Oncol, Barretos - Brazil
[3] Barretos Canc Hosp, Dept Clin Oncol, Barretos - Brazil
[4] Barretos Canc Hosp, Dept Mastol & Breast Reconstruct, Barretos - Brazil
Total Affiliations: 4
Document type: Journal article
Source: CLINICAL BREAST CANCER; v. 19, n. 1, p. E85-E100, FEB 2019.
Web of Science Citations: 1
Abstract

Quality-of-life questionnaires (QLQs) do not correlate with objective measurements of treatment sequelae. We performed a comprehensive validation study of the Brazilian Portuguese version of the Breast Cancer Treatment Outcome Scale (BCTOS), adding physical evaluations of the main sequelae related to breast-conserving therapy (BCT). Three hundred patients were evaluated. BCTOS represented a good QLQ for BCT patients, which correlated with objective measurements. Introduction: When evaluating a quality-of-life questionnaire (QLQ), many validation studies do not correlate qualityof-life scores with objective measurements of complications associated with treatment. Patients and Methods: We performed a cross-sectional observational study with 300 patients submitted to breast-conserving therapy. The patients answered the European Organization for Research and Treatment of Cancer (EORTC) QLQs C-30 and BR23, as well as the Brazilian Portuguese version of the Breast Cancer Treatment Outcome Scale (BCTOS) questionnaire. Retest, internal consistency, factorial analysis, convergent/divergent analysis, and Rasch evaluation were performed. All patients underwent physical evaluations to assess lymphedema, handgrip strength, shoulder range of motion, breast cosmesis, and breast pain, and these groups were compared on the basis of BCTOS scores. Receiver operating characteristic curve determined the predictive value of BCTOS scores associated with clinical practice. Results: The internal consistencies of the BCTOS domains ranged from 0.785 to 0.895. Factor analysis grouped according to the original questionnaire. Convergent validation showed differences in the sexual functioning and sexual enjoyment domains of the EORTC BR23. Analysis of known groups found that in most domains, the scores were higher in patients with lymphedema, strength deficit, shoulder range-of-motion alteration, poor breast cosmesis, breast pain, and axillary lymphadenectomy. Using a cutoff of 1.26, lymphedema was associated with the edema domain; using a cutoff of 1.33, Late Effects Normal Tissue Task Force/Subjective, Objective, Management, Analytic pain was associated with the pain domain; and using a cutoff of 2.37, the cosmetic domain was associated with subjective cosmesis. Conclusion: The association of objective measurements in a validation study of quality of life qualified the study and allowed us to develop better parameters for comparisons of results of breast-conserving therapy between populations. (C) 2018 Elsevier Inc. All rights reserved. (AU)

FAPESP's process: 14/08197-0 - Conservative treatment of breast cancer: validation of tools for qualitative and quantitative evaluation
Grantee:René Aloisio da Costa Vieira
Support type: Regular Research Grants